[
    [
        {
            "time": "2023-10-01",
            "original_text": "ABBV Dividend Yield Pushes Past 4%",
            "features": {
                "keywords": [
                    "ABBV",
                    "Dividend",
                    "Yield",
                    "Pushes",
                    "Past",
                    "4%"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "ABBV Dividend Yield Pushes Past 4%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "XLV, ABBV, AMGN, MDT: ETF Outflow Alert",
            "features": {
                "keywords": [
                    "XLV",
                    "ABBV",
                    "AMGN",
                    "MDT",
                    "ETF",
                    "Outflow",
                    "Alert"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "XLV, ABBV, AMGN, MDT: ETF Outflow Alert",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street",
            "features": {
                "keywords": [
                    "Benzinga's",
                    "Daily",
                    "Biotech",
                    "Pulse",
                    "AbbVie",
                    "Launches",
                    "New",
                    "Pediatric",
                    "Humira",
                    "IPO",
                    "Deluge",
                    "Hits",
                    "The",
                    "Street"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug Makers Equities",
            "features": {
                "keywords": [
                    "Initiating",
                    "Free",
                    "Research",
                    "Reports",
                    "Bristol-Myers",
                    "Squibb",
                    "Three",
                    "Other",
                    "Drug",
                    "Makers",
                    "Equities"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug Makers Equities",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]